David A. Rosa - Feb 14, 2025 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
Director
Signature
/s/ David Rosa
Stock symbol
BRTX
Transactions as of
Feb 14, 2025
Transactions value $
$0
Form type
4
Date filed
2/19/2025, 04:33 PM
Previous filing
Feb 4, 2025
Next filing
Feb 20, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +52.6K $0.00 52.6K Feb 14, 2025 Common Stock 52.6K $2.46 Direct F2
holding BRTX Stock Option 10.5K Feb 14, 2025 Common Stock 10.5K $5.08 Direct F1
holding BRTX Stock Option 32K Feb 14, 2025 Common Stock 32K $2.91 Direct F1
holding BRTX Stock Option 79.6K Feb 14, 2025 Common Stock 79.6K $1.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is currently exercisable.
F2 The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing every month thereafter until fully vested.